How does the metabolism of tumour cells differ from that of normal cells

Bioscience Reports

Volumn 33, Issue 6, 2013, Pages 865-873

  Amoêdo, Nívea Dias ^a   Valencia, Juan Perez ^a   Rodrigues, Mariana Figueiredo ^a   Galina, Antonio ^a   Rumjanek, Franklin David ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Energy; Glutamine; Glycolysis; Hypoxia; Lipids; Mitochondria

Indexed keywords

ABC TRANSPORTER; ALKYLATING AGENT; BROMOPYRUVIC ACID; DNA; GLUCOSE; GLUTAMINE; LIPID; OXYGEN; PROTEIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

AEROBIC METABOLISM; ANAEROBIC GLYCOLYSIS; APOPTOSIS; CARCINOGENESIS; CELL CYCLE; CELL METABOLISM; GENE CONTROL; HUMAN; METASTASIS; MITOCHONDRION; PHENOTYPE; PLASTICITY; PRECURSOR; REVIEW; TUMOR CELL CULTURE; ANIMAL; DRUG EFFECT; ENERGY METABOLISM; GLYCOLYSIS; METABOLISM; MOLECULARLY TARGETED THERAPY; NEOPLASM; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; ENERGY METABOLISM; GLUTAMINE; GLYCOLYSIS; HUMANS; MITOCHONDRIA; MOLECULAR TARGETED THERAPY; NEOPLASMS;

EID: 84888414331     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20130066     Document Type: Review

References (48)

1. DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S. and Thompson, C. B. (2007) Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad Sci. U.S.A. 104, 19345-19350
2. Pelicano, H., Martin, D. S., Xu, R. H. and Huang, P. (2006) Glycolysis inhibition for anticancer treatment. Oncogene 25, 4633-4646
3. Chen, E. I. (2012) Mitochondrial dysfunction and cancer metastasis. J. Bioenerg. Biomembr. 44, 619-622
4. Moreno-Sanchez, R., Rodriguez-Enriquez, S., Marin-Hernandez, A. and Saavedra, E. (2007) Energy metabolism in tumor cells. FEBS J. 274, 1393-1418
5. Kroemer, G. and Pouyssegur, J. (2008) Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 13, 472-482
6. Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C. et al. (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739-744
7. Semenza, G. L. (2010) HIF-1: upstream and downstream of cancer metabolism. Curr. Opin. Genet Dev. 20, 51-56
8. Semenza, G. L. (2011) Regulation of metabolism by hypoxia-inducible factor 1. Cold Spring Harb Symp Quant Biol. 76, 347-353
9. Soga, T. (2013) Cancer metabolism: key players in metabolic reprogramming. Cancer Sci. 104, 275-281
10. Chen, J. Q. and Russo, J. (2012) Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells. Biochim. Biophys. Acta 1826, 370-384
11. Mathupala, S. P., Ko, Y. H. and Pedersen, P. L. (2006) Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene 25, 4777-4786
12. Wong, N., De Melo, J. and Tang, D. (2013) PKM2, a central point of regulation in cancer metabolism. Int. J. Cell Biol. 2013, 242513
13. Curi, R., Newsholme, P., Procopio, J., Lagranha, C., Gorjao, R. and Pithon-Curi, T. C. (2007) Glutamine, gene expression, and cell function. Front. Biosci. 12, 344-357
14. Marquez, J., Tosina, M., de la Rosa, V., Segura, J. A., Alonso, F. J., Mates, J. M. and Campos-Sandoval, J. A. (2009) New insights into brain glutaminases: beyond their role on glutamatergic transmission. Neurochem. Int. 55, 64-70
15. Smith, E. M. and Watford, M. (1990) Molecular cloning of a cDNA for rat hepatic glutaminase. Sequence similarity to kidney-type glutaminase. J. Biol. Chem. 265, 10631-10636
16. Cassago, A., Ferreira, A. P., Ferreira, I. M., Fornezari, C., Gomes, E. R., Greene, K. S., Pereira, H. M., Garratt, R. C., Dias, S. M. and Ambrosio, A. L. (2012) Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism. Proc. Natl. Acad. Sci. U.S.A. 109, 1092-1097
17. Kaelin, Jr,W. G. (2010) New cancer targets emerging from studies of the Von Hippel-Lindau tumor suppressor protein. Ann. N. Y. Acad. Sci. 1210, 1-7
18. Ganapathy, V., Thangaraju, M. and Prasad, P. D. (2009) Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol. Ther. 121, 29-40
19. Wise, D. R., Ward, P. S., Shay, J. E., Cross, J. R., Gruber, J. J., Sachdeva, U. M., Platt, J. M., DeMatteo, R. G., Simon, M. C. and Thompson, C. B. (2011) Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability. Proc. Natl. Acad Sci. U.S.A. 108, 19611-19616
20. Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., Kelleher, J. K., Vander Heiden, M. G., Iliopoulos, O. and Stephanopoulos, G. (2012) Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481, 380-384
21. Yoo, H., Antoniewicz, M. R., Stephanopoulos, G. and Kelleher, J. K. (2008) Quantifying reductive carboxylation flux of glutamine to lipid in a brown adipocyte cell line. J. Biol. Chem. 283, 20621-20627
22. Hanahan, D. and Weinberg, R. A. (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674
23. Vousden, K. H. (2010) Alternative fuel-another role for p53 in the regulation of metabolism. Proc. Natl. Acad Sci. U.S.A. 107, 7117-7118
24. Hu, W., Zhang, C., Wu, R., Sun, Y., Levine, A. and Feng, Z. (2010) Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc. Natl. Acad Sci. U.S.A. 107, 7455-7460
25. Nakajima, E. C. and Van Houten, B. (2013) Metabolic symbiosis in cancer: refocusing the Warburg lens. Mol. Carcinog. 52, 329-337
26. Brand, M. D. and Nicholls, D. G. (2011) Assessing mitochondrial dysfunction in cells. Biochem. J. 435, 297-312
27. Ishikawa, K., Imanishi, H., Takenaga, K. and Hayashi, J. (2012) Regulation of metastasis; mitochondrial DNA mutations have appeared on stage. J. Bioenerg. Biomembr. 44, 639-644
28. Anderson, A. S., Roberts, P. C., Frisard, M. I., McMillan, R. P., Brown, T. J., Lawless, M. H., Hulver, M. W. and Schmelz, E. M. (2013) Metabolic changes during ovarian cancer progression as targets for sphingosine treatment. Exp. Cell Res. 319, 1431-1442
29. Sotgia, F., Whitaker-Menezes, D., Martinez-Outschoorn, U. E., Flomenberg, N., Birbe, R. C., Witkiewicz, A. K., Howell, A., Philp, N. J., Pestell, R. G. and Lisanti, M. P. (2012) Mitochondrial metabolism in cancer metastasis: visualizing tumor cell mitochondria and the 'reverse Warburg effect' in positive lymph node tissue. Cell Cycle 11, 1445-1454
30. Vaupel, P. and Mayer, A. (2012) Availability, not respiratory capacity governs oxygen consumption of solid tumors. Int. J. Biochem. Cell Biol. 44, 1477-1481
31. Jose, C., Melser, S., Benard, G. and Rossignol, R. (2013) Mitoplasticity: adaptation biology of the mitochondrion to the cellular redox state in physiology and carcinogenesis. Antioxid. Redox Signal 18, 808-849
32. Yoshida, S., Tsutsumi, S., Muhlebach, G., Sourbier, C., Lee, M. J., Lee, S., Vartholomaiou, E., Tatokoro, M., Beebe, K., Miyajima, N. et al. (2013) Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis. Proc. Natl. Acad Sci. U.S.A. 110, E1604-E1612
33. Zhao, Y., Butler, E. B. and Tan, M. (2013) Targeting cellular metabolism to improve cancer therapeutics. Cell Death Dis. 4, e532
34. Parsons, D. W., Jones, S., Zhang, X., Lin, J. C., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I. M., Gallia, G. L. et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807-1812
35. Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E. et al. (2010) The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17, 225-234
36. Shoshan, M. C. (2013) Potentiation of anti-cancer treatment by modulators of energy metabolism. Curr. Pharm. Biotechnol. 14, 313-330
37. Oronsky, B. T., Reid, T., Knox, S. J. and Scicinski, J. J. (2012) The scarlet letter of alkylation: a mini review of selective alkylating agents. Transl. Oncol. 5, 226-229
38. Prasad, R. and Goffeau, A. (2012) Yeast ATP-binding cassette transporters conferring multidrug resistance. Annu. Rev. Microbiol. 66, 39-63
39. Lis, P., Zarzycki, M., Ko, Y. H., Casal, M., Pedersen, P. L., Goffeau, A. and Ulaszewski, S. (2012) Transport and cytotoxicity of the anticancer drug 3-bromopyruvate in the yeast Saccharomyces cerevisiae. J. Bioenerg. Biomembr. 44, 155-161
40. Goffeau, A. (2008) Drug resistance: the fight against fungi. Nature 452, 541-542
41. Ko, Y. H., Pedersen, P. L. and Geschwind, J. F. (2001) Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase. Cancer Lett. 173, 83-91
42. Ko, Y. H., Smith, B. L., Wang, Y., Pomper, M. G., Rini, D. A., Torbenson, M. S., Hullihen, J. and Pedersen, P. L. (2004) Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. Biochem. Biophys. Res. Commun. 324, 269-275
43. Mathupala, S. P., Ko, Y. H. and Pedersen, P. L. (2009) Hexokinase-2 bound to mitochondria: cancer's stygian link to the 'Warburg Effect' and a pivotal target for effective therapy. Semin. Cancer Biol. 19, 17-24
44. Pereira da Silva, A. P., El-Bacha, T., Kyaw, N., dos Santos, R. S., da-Silva, W. S., Almeida, F. C., Da Poian, A. T. and Galina, A. (2009) Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate. Biochem. J. 417, 717-726
45. Birsoy, K., Wang, T., Possemato, R., Yilmaz, O. H., Koch, C. E., Chen, W. W., Hutchins, A. W., Gultekin, Y., Peterson, T. R., Carette, J. E. et al. (2013) MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors. Nat. Genet 45, 104-108
46. Kluckova, K., Bezawork-Geleta, A., Rohlena, J., Dong, L. and Neuzil, J. (2013) Mitochondrial complex II, a novel target for anti-cancer agents. Biochim. Biophys. Acta 1827, 552-564
47. Rodrigues-Ferreira, C., da Silva, A. P. and Galina, A. (2012) Effect of the antitumoral alkylating agent 3-bromopyruvate on mitochondrial respiration: role of mitochondrially bound hexokinase. J. Bioenerg. Biomembr. 44, 39-49
48. Jardim-Messeder, D., Camacho-Pereira, J. and Galina, A. (2012) 3-Bromopyruvate inhibits calcium uptake by sarcoplasmic reticulum vesicles but not SERCA ATP hydrolysis activity. Int. J. Biochem. Cell Biol. 44, 801-807